A Phase 3, Randomized, Long-Term Study Evaluating Safety and Efficacy of Treatment in Patients with Nonalcoholic Steatohepatitis (NASH)

August 15, 2018
https://clinicaltrials.gov/ct2/show/NCT02548351
Gastroenterology Hepatology
Principal Investigator: Stuart C Gordon, MD
NASH, nash, nonalcoholic, nonalcoholic steatohepatitis, oca, OCA, fatty liver
Open